US Patent Family Members and Approved Drugs for Russian Federation Patent: 2287574
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Russian Federation Patent: RU2287574
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 6,828,121 | 2022-07-08 | ranibizumab | Genentech, Inc. | LUCENTIS |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
